Questions people ask about Abnehmspritze Frauen

The so-called 'weight loss shot' (GLP-1 agonists like semaglutide, e.g., Wegovy or Ozempic) is increasingly sought by women. Importantly, these are prescription drugs, not supplements or lifestyle products. Evidence for effective weight loss is strong (human-strong) in obesity (BMI ≥ 30) or overweight with comorbidities. However, long-term safety and sustainability data for moderate overweight without medical indication are lacking. Side effects include nausea, vomiting, gallbladder risk, and muscle loss. MyBody-X does not offer such injections; its tests can analyze metabolic markers like blood lipids or fasting glucose but cannot determine suitability for GLP-1 therapy. Marketing often overstates ease of use. The reality: medical supervision is mandatory, and the shot does not replace lasting dietary changes. Evidence for use in women without obesity is weak, mostly based on mechanistic or observational studies.